SISMONDI, Piero

SISMONDI, Piero  

Dip. DISCIPLINE GINECOLOGICHE E OSTETRICHE (attivo dal 01/01/1900 al 30/04/2013)  

Mostra records
Risultati 1 - 20 di 360 (tempo di esecuzione: 0.005 secondi).
Titolo Data di pubblicazione Autore(i) File
[1st experiences in the treatment of benign lesions of the portio using a new apparatus for cryotherapy] 1974 SISMONDI P ;RAPPELLI F ;BOCCI A
3rd TRAINING THE TRAINERS COURSE FOR EDUCATIONAL SUPERVISORS IN OBTETRICS AND GYNAECOLOGY 2010 C. Benedetto; P. Sismondi; L. Marozio; T. Mahmood; M. Obhrai; Z. Novak Antolic
A glossary for reporting complications of treatment in gynecological cancers. 1993 D. CHASSAGNE; P. SISMONDI; J.C. HORIOT; P. BEY; P. ZOLA; M. PERNOT; A. GERBAULET; I. KUNKLER; G. MICHEL
A gonadotrophin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis. 1999 VERCELLINI P; CROSIGNANI PG; FADINI R; RADICI E; BELLONI C; P. SISMONDI
A new technique to test tubal patency under transvaginal sonographic control. 1994 VOLPI E;DE GRANDIS T;RUSTICHELLI S;ZUCCARO G;PATRIARCA A;SISMONDI P
A survey on the menopause after breast cancer. 2001 BIGLIA N; ROAGNA R; COZZARELLA M; PONZONE R; FUSO L; MAGGIOROTTO F; UJCIC E; P. SISMONDI
Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5'-untranslated region 2004 ORSO F; COTTONE E; HASLETON MD; IBBITTCJ; SISMONDI P; HURST HC; DE BORTOLI M
Adapting clinical practice guidelines to a regional oncology network: the Piedmont experience 2007 GELORMINO E; PAGANO E; APPIANO S; CECCARELLI M; CIUFFREDA L; COMANDONE A; FARINA E; MERLETTI F; MUSSA A; PENNA A; PONTI A; RACITI I; SCAGLIOTTI GV; SEGNAN N; SENORE C; SISMONDI P; VINEIS P; BERTETTO O; CICCONE G
Adjuvant chemotherapy with high-dose cyclophosphamide, etoposide and cisplatin intensification without progenitor cell support in breast cancer patients with ten or more involved nodes: 5-year results of a pilot trial. 2001 BALLESTRERO A; RUBAGOTTI A; STURA P; FERRANDO F; AMOROSO D; RINALDINI M; P. SISMONDI; GENTA F; MESITI M; BREMA F; PATRONE F; BOCCARDO F.
Analysis of complications of cervix carcinoma treated by radiotherapy using the Franco-Italian glossary. 1993 SINISTRERO G; P. SISMONDI; A. RUMORE; ZOLA P
Anatomia della mammella 2001 Sismondi P; Ponzone R; Biglia N
[Anatomo-pathological verification of dosimetry using a calculator in curietherapy of cancer of the cervix uteri] 1978 SISMONDI P ;SINISTRERO G ;FESSIA L ;ZOLA P ;FERRARIS R ;REVELLI E
Androgenic progestogens oppose the decrease of insulin-like growth factor I serum level induced by conjugated oestrogens in postmenopausal women. Preliminary report. 1994 CAMPAGNOLI C ;BIGLIA N ;LANZA MG ;LESCA L ;PERIS C ;SISMONDI P
Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival 2003 SFILIGOI C; DE LUCA A; CASCONE I; SORBELLO V; FUSO L; PONZONE R; BIGLIA N; AUDERO E; ARISIO R; BUSSOLINO F; P. SISMONDI; DE BORTOLI M.
Antiemetic efficacy of granisetron in patients with gynecological malignancies. 1997 SISMONDI P ;DANESE S ;GIARDINA G ;GUERCIO E ;RICHIARDI G ;CARNINO F ;FERRARIS C ;LISSONI A ;INGANNI P ;MAGGI R ;BOCCARDO E ;BARBIERI P
Antihormones in prevention and treatment of breast cancer 2006 PONZONE R; BIGLIA N; JACOMUZZI ME; MARIANI L; DOMINGUEZ A; SISMONDI P
Antihormones in prevention and treatment of breast cancer. 2006 Sismondi P; Biglia N; Ponzone R.
AP-2alpha regulates migration of GN-11 neurons via a specific genetic programme involving the Axl receptor tyrosine kinase 2009 Orso F; Jager R; Calogero R.A.; Schorle H; Sismondi P; De Bortoli M; Taverna D
AP-2{alpha} and AP-2{gamma} regulate tumor progression via specific genetic programs 2008 ORSO F; PENNA E; CIMINO D; ASTANINA E; MAIONE F; VALDEMBRI D; GIRAUDO E; SERINI G; SISMONDI P; DE BORTOLI M; TAVERNA D
Aromatase inhibitors for breast cancer: different structures, same effects? 2008 PONZONE R; MININANNI P; CASSINA E; PASTORINO F; SISMONDI P